Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis

Table 2 Inputs for the multivariate sensitivity analyses

Parameter	Type	Mid-Point	Range
Pre-FTC cost	Triangular	$432	$279 – $584
FTC in Community cost	Triangular	$903	$584 – $1,222
FTC in Institution cost	Triangular	$3,931	$2,543 – $5,319
% FTC in Institution	Triangular	73.5%	47% – 100.0%
Cognitive effect	Normal^†	See Table 1 for means and ranges
Withdrawal Risk	Normal^† of Log RR^‡	See Table 1 for means and ranges

^† all normal distributions were bounded at their two standard deviations ^‡ relative risk of withdrawing from treatment, compared to untreated patients

ISSN: 1471-2318